Previous 10 | Next 10 |
3 Penny Stocks To Watch After Crypto News Crashes Digital Asset Prices Penny stocks are well-known for their high-risk nature. But lately, things like bitcoin price and cryptocurrency news have gotten wrapped into the fold. In particular, when cryptos like Dogecoin and Ethereum bega...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Preventing misdiagnosis is a major priority in the medical community. Connecticut-based Precipio (NASDAQ: PRPO ) seeks to address this by providing a higher standard of diagnostic accuracy, while also offering va...
NEW HAVEN, Conn., May 14, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q1-2021 corporate update call on Thursday, May 20 th at 5:00 PM ET. The call will include updates on all of the company’s current co...
Are These the Best Biotech Penny Stocks Today? We’ve been covering the trend of biotech penny stocks for quite some time. And, with social media sites like Reddit only helping to push this industry up, the challenge to find the best ones is palpable. Many find it difficult to mak...
Gainers: Protagenic Therapeutics (PTIX) +67%.Obalon Therapeutics (OBLN) +57%.Precipio (PRPO) +35%.Cue Biopharma (CUE) +31%.SemiLEDs (LEDS) +28%.CKX Lands (CKX) +27%.Tecnoglass (TGLS) +24%.Soliton (SOLY) +24%.Party City Holdco (PRTY) +19%.uCloudlink (UCL) +16%.Losers: Rekor...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The week has only just started but there’s plenty of volatile stocks that investors need to be wary of on Monday. We’re taking a look at the stocks with the most volatile trading as large numbers of shares cha...
Specialty diagnostics company Precipio shares climb ([[PRPO]] +25.8%) after launching a new, four-hour Acute Myeloid Leukemia ((AML)) HemeScreen panel to specifically determine the genetics of the aggressive, acute form of leukemia.The panel is expected to increase revenues to Oncol...
Gainers: Protagenic Therapeutics (PTIX) +44%, Cue Biopharma CUE +36%, Obalon Therapeutics (OBLN) +28%, Soliton SOLY +24%, Precipio (PRPO) +20%.Losers: Insmed INSM -17%, Soligenix (SNGX) -17%, Kodiak Sciences (KOD) -14%, Dynavax ...
NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML) HemeScreen panel to specifically determine the genetics of this aggressive, acute for...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks jumped to record levels on Friday despite a disappointing April jobs report that showed non-farm payrolls rising by only 266,000 compa...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO) for Q2-2024 was $0.3M of cash generated for the quarter. It is important to not...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...